Published on
December 3, 2025
- 05:30 GMT
Life Seal Vascular Announces Successful Treatment of First Two Patients in the ASCEND First-in-Human Study
Life Seal Vascular treats first two patients in ASCEND FIH study, successfully implanting the Cygnum ASMD as an adjunct to EVAR for active sac management. LAKE FOREST, CA, UNITED STATES, December 2, 2025 /EINPresswire.com/ -- Life Seal Vascular, Inc., a …
Distribution channels:
Business & Economy, Companies
...
